Gene, Cell and Tissue

Published by: Kowsar

Evaluation of Zataria multiflora Boiss. (Shirazi Thyme) Hydro Alcoholic Extract Effect on Pro-Inflammatory Cytokine IL-6 Different Transcript Variants Expression Level in Mesenchymal Stem Cells (MSCs)

Afsaneh Nazari 1 , Sanaz Mahmazi 1 , * and Zeinab Sahraian 2
Authors Information
1 Department of Genetics, Faculty of Basic Sciences, Islamic Azad University, Zanjan Branch, Zanjan, Iran
2 Department of Physiology, Faculty of Basic Sciences, Islamic Azad University, Zanjan Branch, Zanjan, Iran
Article information
  • Gene, Cell and Tissue: October 31, 2018, 5 (4); e82463
  • Published Online: December 19, 2018
  • Article Type: Research Article
  • Received: July 22, 2018
  • Revised: December 11, 2018
  • Accepted: December 16, 2018
  • DOI: 10.5812/gct.82463

To Cite: Nazari A, Mahmazi S, Sahraian Z. Evaluation of Zataria multiflora Boiss. (Shirazi Thyme) Hydro Alcoholic Extract Effect on Pro-Inflammatory Cytokine IL-6 Different Transcript Variants Expression Level in Mesenchymal Stem Cells (MSCs), Gene Cell Tissue. 2018 ; 5(4):e82463. doi: 10.5812/gct.82463.

Abstract
Copyright © 2018, Gene, Cell and Tissue. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Footnotes
References
  • 1. Kavanaugh A. Interleukin-6 inhibition and clinical efficacy in rheumatoid arthritis treatment--data from randomized clinical trials. Bull NYU Hosp Jt Dis. 2007;65 Suppl 1:S16-20. [PubMed: 17708740].
  • 2. Tanaka T, Kishimoto T. The biology and medical implications of interleukin-6. Cancer Immunol Res. 2014;2(4):288-94. doi: 10.1158/2326-6066.CIR-14-0022. [PubMed: 24764575].
  • 3. Yoshizaki K. [Clinical significance of cytokines-interleukin 6 in disease]. Rinsho Byori. 1990;38(4):375-9. Japanese. [PubMed: 2366383].
  • 4. O'Reilly S, Cant R, Ciechomska M, van Laar JM. Interleukin-6: A new therapeutic target in systemic sclerosis? Clin Transl Immunology. 2013;2(4). e4. doi: 10.1038/cti.2013.2. [PubMed: 25505952]. [PubMed Central: PMC4232056].
  • 5. Md Yusof MY, Emery P. Targeting interleukin-6 in rheumatoid arthritis. Drugs. 2013;73(4):341-56. doi: 10.1007/s40265-013-0018-2. [PubMed: 23456676].
  • 6. Kishimoto T. IL-6: From its discovery to clinical applications. Int Immunol. 2010;22(5):347-52. doi: 10.1093/intimm/dxq030. [PubMed: 20410258].
  • 7. Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond). 2012;122(4):143-59. doi: 10.1042/CS20110340. [PubMed: 22029668].
  • 8. Denessiouk KA, Denesyuk AI, Johnson MS. Negative modulation of signal transduction via interleukin splice variation. Proteins. 2008;71(2):751-70. doi: 10.1002/prot.21756. [PubMed: 17979192].
  • 9. Zilberstein A, Ruggieri R, Korn JH, Revel M. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J. 1986;5(10):2529-37. doi: 10.1002/j.1460-2075.1986.tb04531.x. [PubMed: 3023045]. [PubMed Central: PMC1167149].
  • 10. Kestler DP, Agarwal S, Cobb J, Goldstein KM, Hall RE. Detection and analysis of an alternatively spliced isoform of interleukin-6 mRNA in peripheral blood mononuclear cells. Blood. 1995;86(12):4559-67. [PubMed: 8541546].
  • 11. Kestler DP, Goldstein KM, Agarwal S, Fuhr JE, Andrews R, Hall RE. Hematopoietic differentiation activity of a recombinant human interleukin-6 (IL-6) isoform resulting from alternatively spliced deletion of the second exon. Am J Hematol. 1999;61(3):169-77. doi: 10.1002/(SICI)1096-8652(199907)61:3<169::AID-AJH3>3.0.CO;2-9. [PubMed: 10398309].
  • 12. Tanaka T, Narazaki M, Masuda K, Kishimoto T. Interleukin-6; pathogenesis and treatment of autoimmune inflammatory diseases. Inflamm Regen. 2013;33(1):54-65. doi: 10.2492/inflammregen.33.054.
  • 13. Lukaszewicz M, Mroczko B, Szmitkowski M. [Clinical significance of interleukin-6 (IL-6) as a prognostic factor of cancer disease]. Pol Arch Med Wewn. 2007;117(5-6):247-51. Polish. doi: 10.20452/pamw.144. [PubMed: 18030875].
  • 14. Mesquida M, Leszczynska A, Llorenc V, Adan A. Interleukin-6 blockade in ocular inflammatory diseases. Clin Exp Immunol. 2014;176(3):301-9. doi: 10.1111/cei.12295. [PubMed: 24528300]. [PubMed Central: PMC4008973].
  • 15. Keller ET, Wanagat J, Ershler WB. Molecular and cellular biology of interleukin-6 and its receptor. Front Biosci. 1996;1:d340-57. doi: 10.2741/A136. [PubMed: 9159238].
  • 16. Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10). a016295. doi: 10.1101/cshperspect.a016295. [PubMed: 25190079]. [PubMed Central: PMC4176007].
  • 17. Simpson RJ, Hammacher A, Smith DK, Matthews JM, Ward LD. Interleukin-6: Structure-function relationships. Protein Sci. 1997;6(5):929-55. doi: 10.1002/pro.5560060501. [PubMed: 9144766]. [PubMed Central: PMC2143693].
  • 18. van Rhee F, Wong RS, Munshi N, Rossi JF, Ke XY, Fossa A, et al. Siltuximab for multicentric Castleman's disease: A randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2014;15(9):966-74. doi: 10.1016/S1470-2045(14)70319-5. [PubMed: 25042199].
  • 19. Gazdic M, Volarevic V, Arsenijevic N, Stojkovic M. Mesenchymal stem cells: A friend or foe in immune-mediated diseases. Stem Cell Rev. 2015;11(2):280-7. doi: 10.1007/s12015-014-9583-3. [PubMed: 25592610].
  • 20. Ghannam S, Bouffi C, Djouad F, Jorgensen C, Noel D. Immunosuppression by mesenchymal stem cells: Mechanisms and clinical applications. Stem Cell Res Ther. 2010;1(1):2. doi: 10.1186/scrt2. [PubMed: 20504283]. [PubMed Central: PMC2873698].
  • 21. Maitra B, Szekely E, Gjini K, Laughlin MJ, Dennis J, Haynesworth SE, et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 2004;33(6):597-604. doi: 10.1038/sj.bmt.1704400. [PubMed: 14716336].
  • 22. Duffy MM, Ritter T, Ceredig R, Griffin MD. Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther. 2011;2(4):34. doi: 10.1186/scrt75. [PubMed: 21861858]. [PubMed Central: PMC3219065].
  • 23. Zhao Q, Ren H, Han Z. Mesenchymal stem cells: Immunomodulatory capability and clinical potential in immune diseases. J Cell Immunother. 2016;2(1):3-20. doi: 10.1016/j.jocit.2014.12.001.
  • 24. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: Characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med. 2004;8(3):301-16. doi: 10.1111/j.1582-4934.2004.tb00320.x. [PubMed: 15491506].
  • 25. Charbord P. Bone marrow mesenchymal stem cells: Historical overview and concepts. Hum Gene Ther. 2010;21(9):1045-56. doi: 10.1089/hum.2010.115. [PubMed: 20565251]. [PubMed Central: PMC4823383].
  • 26. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001;98(8):2396-402. [PubMed: 11588036].
  • 27. Silva WA Jr, Covas DT, Panepucci RA, Proto-Siqueira R, Siufi JL, Zanette DL, et al. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells. 2003;21(6):661-9. doi: 10.1634/stemcells.21-6-661. [PubMed: 14595126].
  • 28. Crisostomo PR, Wang M, Herring CM, Markel TA, Meldrum KK, Lillemoe KD, et al. Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: Role of the 55 kDa TNF receptor (TNFR1). J Mol Cell Cardiol. 2007;42(1):142-9. doi: 10.1016/j.yjmcc.2006.09.016. [PubMed: 17070836]. [PubMed Central: PMC1779905].
  • 29. Jenhani F, Durand V, Ben Azouna N, Thallet S, Ben Othmen T, Bejaoui M, et al. Human cytokine expression profile in various conditioned media for in vitro expansion bone marrow and umbilical cord blood immunophenotyped mesenchymal stem cells. Transplant Proc. 2011;43(2):639-43. doi: 10.1016/j.transproceed.2011.01.021. [PubMed: 21440783].
  • 30. Sajed H, Sahebkar A, Iranshahi M. Zataria multiflora Boiss. (Shirazi thyme)--an ancient condiment with modern pharmaceutical uses. J Ethnopharmacol. 2013;145(3):686-98. doi: 10.1016/j.jep.2012.12.018. [PubMed: 23266333].
  • 31. Bazargani-Gilani B, Tajik H, Aliakbarlu J. Physicochemical and antioxidative characteristics of Iranian pomegranate (Punica granatum L. cv. Rabbab-e-Neyriz) juice and comparison of its antioxidative activity with Zataria multiflora Boiss essential oil. Vet Res Forum. 2014;5(4):313-8. [PubMed: 25610584]. [PubMed Central: PMC4299998].
  • 32. Sodouri M, Masoudi Alavi N, Fathizadeh N, Taghizadeh M, Azarbad Z, Memarzadeh M. Effects of zataria multi-flora, Shirazi thyme, on the severity of premenstrual syndrome. Nurs Midwifery Stud. 2013;2(4):57-63. doi: 10.5812/nms.13709. [PubMed: 25414880]. [PubMed Central: PMC4228904].
  • 33. Ayesh BM, Abed AA, Faris DM. In vitro inhibition of human leukemia THP-1 cells by Origanum syriacum L. and Thymus vulgaris L. extracts. BMC Res Notes. 2014;7:612. doi: 10.1186/1756-0500-7-612. [PubMed: 25194985]. [PubMed Central: PMC4175567].
  • 34. Siebert S, Tsoukas A, Robertson J, McInnes I. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases. Pharmacol Rev. 2015;67(2):280-309. doi: 10.1124/pr.114.009639. [PubMed: 25697599].
  • 35. Fonseka TM, McIntyre RS, Soczynska JK, Kennedy SH. Novel investigational drugs targeting IL-6 signaling for the treatment of depression. Expert Opin Investig Drugs. 2015;24(4):459-75. doi: 10.1517/13543784.2014.998334. [PubMed: 25585966].
  • 36. Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, Ramm G, et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes. 2006;55(10):2688-97. doi: 10.2337/db05-1404. [PubMed: 17003332].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments